Please provide your email address to receive an email when new articles are posted on . Patients were more likely to achieve sustained remission with sarilumab vs. placebo. The most common adverse ...
The REPLENISH trial finds secukinumab doubles the remission rate and significantly lowers steroid use in relapsing ...
DEAR DR. ROACH: I was recently diagnosed with polymyalgia rheumatica after weeks of intense muscle pain. I’m a 67-year-old female in otherwise good health. My doctor prescribed prednisone, which ...
DelveInsight's " Polymyalgia Rheumatica Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Polymyalgia Rheumatica, historical and forecasted ...
The therapeutic landscape for polymyalgia rheumatica (PMR) has grown and will grow further, allowing prolonged use of glucocorticoids (GCs) to be minimized, Anisha B. Dua, MD, MPH, of Feinberg School ...
Credit: Shutterstock. Patients in the sarilumab vs placebo group achieved sustained remission of polymyalgia rheumatica at higher rates. Sarilumab demonstrates significant efficacy and is safe in the ...
PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both rheumatology and ...
Polymyalgia rheumatica (PMR) is a systemic inflammatory disorder that predominantly affects individuals over the age of 50. It is characterised by pain and stiffness in the shoulder and hip girdles, ...
Novartis said that its immunology drug Cosentyx met the primary target and all secondary ones in a late-stage trial for the treatment of patients with inflammatory disease polymyalgia rheumatica.
DEAR DR. ROACH: I was recently diagnosed with polymyalgia rheumatica after weeks of intense muscle pain. I’m a 67-year-old female in otherwise good health. My doctor prescribed prednisone, which ...
Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. So this is a work in progress and we need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results